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Serotonin is one of the most important neurotransmitters involved in emotional 
regulation, which affect decision-making. In fact, specific genes regulate the trans-
porter protein of serotonin, making people prone to show or not higher amygdala 
activation. Higher activation of specific components of the limbic system, such as 
amygdala, results in a higher susceptibility to make decision taking into account 
the environmental and emotional aspects and not only rational elaborations of 
the facts. It makes the response of decision-making more visceral or emotional in 
contrast to people with lower amygdala activation. Therefore, the importance of 
serotonin regulations impacts on daily and important decisions.
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1. Introduction
Nowadays, decision-making has been considered as one of the most complex 
cognitive functions that use other superior processes such as learning, memory, and 
feedback sensibility [1]. Theoretically, when people have to make a decision, they 
are placed on a continuum of uncertainty being “complete ignorance” one pole and 
“certainty” the other one [2]. In this case, there are difficulties to identify the level 
of uncertainty (ambiguity), it could be impossible to determine the probability 
of gain or loss, regardless of the fact that consequences are established and clearly 
known. In contrast, in those situations where there is risk of uncertainty, although 
the consequences are stable and clearly known too, gain of fail result can be calcu-
lated. So, accordingly, decisions can be made considering as key construct the range 
of ambiguity or risk of uncertainty [2, 3].
The cognitive-experiential theory supported by Epstein’s group [4] distinguishes 
between two qualitative systems of information processing in decision-making: the 
rational and the experiential system. The rational style of thinking is character-
ized by a free emotional perspective, which results in a more analytic, conscious, 
and effortful process. In contrast, the experiential system is based on emotions, 
being more automatic, effortless, imaginative, and unconscious (Epstein, 2010). 
Interestingly, the way people process the inputs from the environment and make 
decisions is considered in two ways: analytical and intuitive [5]. So, the thinking 
styles and the decision-making styles probably share an important background. 
But, decision-making is considered independently from emotional processes and 
brain neurochemical balance. In this chapter, we will summarize the physiological 
overlapping between emotional and decision-making processes and the effect of 
serotonin neurotransmitter on the modulation of these cognitive functions.
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2. Main brain regions involved in emotions and decision-making
The main brain structure involved in decision-making is the prefrontal cortex 
(PFC), which is considered nowadays as the main location of executing cogni-
tive functions. In fact, it has been considered the PFC as the central key structure 
for cognitive functions as attention for relevant environmental stimuli, objective 
selection, cognitive control, planning, and monitoring performance [6, 7]. For 
goal-directed behavior [8] and attention [9–11], subcortical and thalamic regions 
are involved together with the PFC leading to a complex top-down cognitive control 
network. In this line, behaviors controlled by other subcortical or cortical areas out 
of PFC control network become habits or inflexible behaviors, mostly dependent on 
simple sensory motor associations [12].
It is important to take into account that the PFC region is controlled by subcorti-
cal regions involved in emotional processing such as amygdala or nucleus accum-
bens (NAc) [13, 14]. Both are considered key structures in processing the signal of 
the environmental stimuli, taking into account the emotional valence, in order to 
classify them as appetitive or aversive [15–17]. At the same time, PFC is connected 
with the orbitofrontal cortex (OFC) in voluntary choices and to the anterior cingu-
late cortex (ACC) in monitoring the outcome of our choices [18, 19]. These connec-
tions support the well-known effect of emotions on decision-making. In fact, lesion 
model studies performed with rats and nonhuman primates showed that NAc injury 
affects negatively response inhibition and cognitive flexibility [20–22]; meanwhile, 
amygdala inactivation or lesion affects the selection of relevant information, which 
is needed in situations with emotional value to coordinate cognitive, physiological, 
and behavioral responses [17, 23, 24].
Interestingly, although the dorsolateral prefrontal cortex (DLPFC) has been 
considered as the cognitive brain region per excellence [25, 26], there is growing 
evidence suggesting that DLPFC plays an important role in emotional regulation 
and motivated behavior [27–32].
3. Physiological overlapping between emotions and decision-making
When someone has to choose between doing something or not, he balances the 
immediate reward of doing it as well as the risk of incurring future negative conse-
quences. This fact is known as the concept of willpower, which involves two brain 
systems’ activation: the impulsive system and the reflective system [33] (see Figure 1). 
According to that, the decision-making process will mainly depend on neural sub-
strates, which are affected by emotions because of the modulation that feelings make 
on neurotransmitter systems.
Main structures involved in the impulsive system are amygdala and striatum 
[33], which are the structures involved in short lived and very quick responses 
[34]. As we explained above, amygdala is responsible for attributing affective or 
emotional value to stimuli perceived evoked through hypothalamus and autonomic 
brainstem nuclei, which produce changes in internal milieu and visceral structures 
(e.g., striatum and periaqueductal gray) [35]. Amygdala plays a role in emotional 
decision-making, even in stimuli with an affective value learned by experience (e.g., 
money or drugs). It has been shown that autonomic response to the gain or loss of 
important amounts of money depends on the amygdala integrity [1]. In the same 
line, in addicts, it has been show an exacerbated autonomic response similar to 
monetary gains [36], which could be related to abnormal activity in the amygdala-
ventral striatum system that probably would result in a heightened reward percep-
tion of the stimuli [
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In contrast, the reflective system involves hippocampus, insula, AC, and PFC 
structures (ventromedial prefrontal cortex—VMPC, lateral orbitofrontal, inferior 
frontal gyrus, and DLPFC) [33]. The VMPC is crucial to induce affective states 
from recall to imagination, because it is responsible to reactivate the pattern of the 
affective state experienced in the past of reward or punishment that was developed 
from the brainstem nuclei [35] and to which the brain preserves the neural pattern 
[1]. In fact, patients with damage or people with functional abnormalities in VMPC 
[1] (Erns and Paulus, 2005) show impairments in decision-making. However, the 
normal function of the VMPC depends on the integrity of other neural systems. The 
insula, hippocampus, DLPFC, and somatosensory cortices need to be preserved for 
representing patterns of emotional or affective states and memory, but they need to 
preserve their integrity for the correct functioning of the VMPC too. Impairments 
in decision -making in patients with right parietal damage [1] and in people with 
functional abnormalities (Erns and Paulus, 2005), including the insula and somato-
sensory cortex, have been observed. Same difficulties in decision-making have been 
observed in patients with damage on DLPFC (Clark, Cools and Robbins, 2004). For 
these reasons, it can be concluded that the decision-making process depends directly 
on the correct functioning of other brain systems involved in memory and emotional 
regulation [33]. This neural overlapping suggests a functional interconnection 
between memory, emotions, and decision-making cognitive processes, being all con-
nections between these brain systems are located in VMPC [1] (Clark et al., 2004).
In line with those exposed above, Rolls [38] highlights the importance of emo-
tions in decision-making processes giving the fact that the resulting behavior of a 
decision is the consequence of two brain systems (see Figure 2). On the one hand, 
the emotional system is responsible for the behavior directed to reward or avoidance 
of punishment in terms of aptitude to natural selection [39–41]. OFC and amygdala 
have been related to the reward process [39], giving a reward/affective value of the 
stimulus processed firstly by sensorial main structures (see Figure 2). In contrast, the 
cognitive system depends on the frontoparietal network and responds to declarative 
knowledge and explicit goals [38]. The main contribution of Rolls [38, 39] was the 
stablishment of the role of lateral PFC, which is considered the hub of modulation of 
emotion circuity able to bias our behavior and conduct it agreeing to our explicit goals.
Figure 1. 
Diagram from key structures involved in the impulsive (red) and reflective system (blue). A: amygdala, 
VMPC: ventromedial prefrontal cortex, AC: anterior cingulate, DLPC: dorsolateral prefrontal cortex, hip: 
hippocampus, DA: dopamine, and 5-HT: serotonin. Extracted from Ref. [33].
Serotonin
4
4. Serotonin as key neurotransmitter in emotional decision-making
Why is serotonin the hub of decision-making? Considering the neural correla-
tion explained above which regulates emotions and decision-making, the following 
question to consider is which neurotransmitter regulates these networks.
Neuroanatomical studies described the brain regions mainly regulated by 
serotonin. It has been stated that serotoninergic neurons are located mainly in 
the brainstem raphe nuclei [42] and project to numerous cortical and subcortical 
regions. The innervation of serotoninergic neuron from this area projects to the 
PFC, amygdala, and NA as well as to the ventral tegmental area (VTA), which have 
been related to reward processes, emotions, and decision-making [13, 14, 43]. 
Interestingly, the medial areas from PFC play a top-down regulation from these 
serotoninergic regions acting as a self-feedback regulation mechanism [44]. But 
there is a big amount of brain regions sensible to the serotonin neurotransmitter, 
the effect of which depends on the receptor located in the region. Specifically, 
5-HT1A receptors are found mainly at hippocampus, hypothalamus, and septum 
Figure 2. 
Schematic diagram showing some of the connections of the taste, olfactory, somatosensory, and visual pathways 
in the brain. V1, primary visual (striate) cortex; V2 and V4, further cortical visual areas. PFC, prefrontal 
cortex. VPL, ventroposterolateral nucleus of the thalamus, which conveys somatosensory information to the 
primary somatosensory cortex (areas 1–3). VPMpc, ventro-postero-medial nucleus pars parvocellularis of the 
thalamus, which conveys the taste information to the primary taste cortex. Pregen Cing, pregenual cingulate 
cortex. For the purpose of description, the stages can be described as Tier 1, representing what object is present 
independently of reward value; Tier 2 in which reward value is represented; and Tier 3 in which decisions 
between stimuli of different values are taken, and in which the value is interfaced to behavioral output systems. 
Extracted from Rolls [39].
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which are part of the brain networks suggested as part of the different ways of 
decision-making process [45]. In contrast, 5-HT1B receptors are found mainly on 
deep subcortical structures as globus pallidus, substantia nigra, ventral pallidum, 
and dorsal subiculum [46, 47]. The 5-HT2A receptors from medial PFC are located 
practically exclusively on dendrites of local neuron circuits and spines of pyramidal 
neurons [48]. Moreover, 5-HT2A receptors can be found on amygdala, hippocam-
pus, and frontal, piriform and entorhinal cortices, as it happens with 5-HT2C [49]. 
Finally, 5-HT6 receptors are mainly expressed on the cerebral cortex, NA, striatum, 
and hippocampus [50].
Apart from neuroanatomical evidence highlighting the sensitivity from brain 
structures related to emotional processing and decision-making processes, one of 
the most important evidence of the key role of serotonin in these processes is using 
drugs to regulate serotonin release [51]. For example, the use of serotonin reuptake 
inhibitors (SSRIs) is one of the most important antidepressants used in depression 
and obsessive compulsive disorder [52, 53]. Interestingly, there are evidence that 
SSRI treatment, being effective reducing depressive symptom, improves decision-
making and the sensitivity to positive feedback [54]. In this line, serotonin helps 
to predict future punishment [55] and affects the process of positive stimuli [54]. 
Increasing serotonin levels can block the uptake of serotonin released in synaptic 
space using, for example, SSRIs. These drugs, applied acutely, increase serotonin 
concentration in terminal regions, as well as reduce serotonin concentrations in 
raphe nuclei due to the activate 5-HT1A receptor [56, 57]. Although these drugs have 
been considered one of the most efficient ways to increase serotonin levels, it has 
been observed negative effects on brain development when they have been used 
in young individuals [58], and to several alterations of the balance of other neu-
rotransmitter systems [59].
Interestingly, there is a big amount of studies interested on genetic basis of 
serotonin, mood disorders, and cognitive functioning. Along the different genetic 
studies done about serotonin, it can be highlighted the role of 5-HTTLPR s-allele, 
which has been strongly related to anxiety traits, poor SSRI treatment response and 
increase of prefrontal activity [60]. C(−1019)G 5-HT1A polymorphism increases 
the risk of depressive disorder as well as reduces the efficacy of SSRI drug treatment 
[61]. And in the case of G-697C, polymorphism from 5-HT2C is related to suicide 
[62]. Regarding 5-HT3A and 5-HT3B, which show a large variety of polymorphisms, 
they have been related to major depressive disorder [63].
Regardless of the evidence showed till now, recent studies are still trying to 
clarify the role of serotonin in the decision-making process. In fact, decision-
making should be considered as a complex sequence of different superior process, 
making difficult to deeply understand the role of serotonin in each phase of brain 
subtasks that involves the decision-making process. In fact, the main subprocesses 
of decision-making with serotonin that has been considered key moderator are 
reversal learning, attentional set shifting, reinforce devaluation, delay discounting, 
and response inhibition (see [51]). In fact, Homberg [51] concluded that sero-
tonin acts as an integrating internal and external information, affecting cognitive 
functioning: when serotonin is high, there is a high vigilance behavior increasing 
therefore the top-down PFC control which leads to an improved reversal learning, 
attentional set shifting, and response inhibition meanwhile decreases delay dis-
counting. In contrast, when serotonin is low, the top-down PFC is low too leading to 
an impaired reversal learning, reduced attentional set shifting as well as decreased 
response inhibition; meanwhile, delay discounting turns high. In conclusion, 
serotonin regulation affects brain region functioning involved in the subtask, which 
depends on the decision-making process.
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